Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Technologies, GenVault

Premium

Third Wave Technologies launched its Invader hepatitis C virus genotyping reagents. The product enables clinical labs to develop assays that identify all six genotypes of the HCV virus. Physicians prescribe the test to choose a therapy, determine disease progression, and track drug response.


GenVault launched a lab-scale DNA storage system, and said the Intramural Research Program of the National Institute on Aging has ordered two of the platforms.

The NIA uses GenVault’s 384-well microplates, called GenPlates, which hold DNA in a format that can be stored and shipped at room temperature without special biohazard labeling and treatment. (GenVault said data show that DNA is “stably preserved” in this form and that it may be extracted and purified “with a few buffer washes.”

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.